Published in Clin Endocrinol (Oxf) on August 08, 2014
Puberty Related Intervention to Improve Metabolic Outcomes (The PRIMO Study) (PRIMO) | NCT01410643
Mediators of Kidney-Bone Communication in Childhood (PAKC) | NCT02040740
Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals. J Clin Transl Endocrinol (2015) 0.77
Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations. Int J Obes (Lond) (2015) 0.76
Bone Mineral Content as a Driver of Energy Expenditure in Prepubertal and Early Pubertal Boys. J Pediatr (2015) 0.75
Variations in pattern of pubertal changes in girls. Arch Dis Child (1969) 23.35
Variations in the pattern of pubertal changes in boys. Arch Dis Child (1970) 16.22
FGF-21 as a novel metabolic regulator. J Clin Invest (2005) 10.69
Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab (2007) 9.62
Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab (2007) 9.34
Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes (2008) 5.62
Pathogenesis of type 2 diabetes mellitus. Med Clin North Am (2004) 4.44
Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes (1999) 3.68
Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr (2007) 3.45
The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. Cell Metab (2008) 3.34
Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. Proc Natl Acad Sci U S A (2012) 2.38
FGF21 is an Akt-regulated myokine. FEBS Lett (2008) 2.29
Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health (1992) 2.16
Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes (2007) 2.13
Girls at five are intrinsically more insulin resistant than boys: The Programming Hypotheses Revisited--The EarlyBird Study (EarlyBird 6). Pediatrics (2004) 1.55
Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes (2009) 1.51
FGF21 promotes metabolic homeostasis via white adipose and leptin in mice. PLoS One (2012) 1.47
Effect of puberty on body composition. Curr Opin Endocrinol Diabetes Obes (2009) 1.45
Changes in risk variables of metabolic syndrome since childhood in pre-diabetic and type 2 diabetic subjects: the Bogalusa Heart Study. Diabetes Care (2008) 1.34
Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab (1995) 1.33
Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine. Am J Physiol Endocrinol Metab (2013) 1.21
Adipo-myokines: two sides of the same coin--mediators of inflammation and mediators of exercise. Mediators Inflamm (2013) 1.19
FGF21 as an Endocrine Regulator in Lipid Metabolism: From Molecular Evolution to Physiology and Pathophysiology. J Nutr Metab (2011) 1.19
Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. J Clin Endocrinol Metab (2012) 1.15
New predictors of the metabolic syndrome in children--role of adipocytokines. Pediatr Res (2007) 1.06
Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage. J Clin Endocrinol Metab (2013) 1.04
Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate. J Biol Chem (2012) 0.99
Sexual dimorphism of body composition and insulin sensitivity across pubertal development in obese Caucasian subjects. Eur J Endocrinol (2009) 0.98
Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity/type 2 diabetes mellitus. Physiol Res (2009) 0.98
Measuring insulin sensitivity in youth: How do the different indices compare with the gold-standard method? Diabetes Metab (2010) 0.97
Sexual dimorphism in insulin sensitivity and susceptibility to develop diabetes in rats. J Endocrinol (2006) 0.94
Fibroblast growth factor 21 (FGF21) and bone: is there a relationship in humans? Osteoporos Int (2013) 0.87
Elevated FGF21 secretion, PGC-1α and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle. Hum Mol Genet (2013) 0.85
Reduced carbohydrate diet to improve metabolic outcomes and decrease adiposity in obese peripubertal African American girls. J Pediatr Gastroenterol Nutr (2012) 0.82
Adipocytokine profile and insulin resistance in childhood obesity. Maedica (Buchar) (2012) 0.81
Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation. Int J Obes (Lond) (2013) 0.79
[Adipocytokines concentration and metabolic parameters in obese children]. Pediatr Endocrinol Diabetes Metab (2011) 0.77
FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA (2011) 5.86
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int (2011) 4.74
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease. Kidney Int (2009) 3.41
Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol (2008) 3.26
High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. Am J Clin Nutr (2013) 2.66
Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. Nephrol Dial Transplant (2011) 2.60
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant (2010) 2.23
Cardiovascular risk factors in CKD associate with both ESRD and mortality. J Am Soc Nephrol (2013) 1.78
Serum 25-hydroxyvitamin D and parathyroid hormone are independent determinants of whole-body insulin sensitivity in women and may contribute to lower insulin sensitivity in African Americans. Am J Clin Nutr (2010) 1.74
Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications. Clin J Am Soc Nephrol (2011) 1.62
Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int (2010) 1.47
Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease. J Ren Nutr (2012) 1.46
Statement of concern about a commercial assay used to measure soluble hemojuvelin in humans. Am J Nephrol (2012) 1.31
Effect of dietary adherence with or without exercise on weight loss: a mechanistic approach to a global problem. J Clin Endocrinol Metab (2009) 1.21
Do neighbourhoods matter? Neighbourhood disorder and long-term trends in serum cortisol levels. J Epidemiol Community Health (2010) 1.11
Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr (2010) 1.09
High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr (2012) 1.03
Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study. Am J Kidney Dis (2012) 1.02
Dietary patterns are associated with incident stroke and contribute to excess risk of stroke in black Americans. Stroke (2013) 1.02
Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. Diabetes Res Clin Pract (2012) 1.01
Prevalence of apparent treatment-resistant hypertension among individuals with CKD. Clin J Am Soc Nephrol (2013) 0.99
Neighborhood-level disadvantage is associated with reduced dietary quality in children. J Am Diet Assoc (2009) 0.99
Parental feeding practices and socioeconomic status are associated with child adiposity in a multi-ethnic sample of children. Appetite (2011) 0.94
Dietary macronutrient composition affects β cell responsiveness but not insulin sensitivity. Am J Clin Nutr (2011) 0.91
Divergent effects of obesity on bone health. J Clin Densitom (2013) 0.91
A conserved role for syndecan family members in the regulation of whole-body energy metabolism. PLoS One (2010) 0.90
The relationships among total body fat, bone mineral content and bone marrow adipose tissue in early-pubertal girls. Bonekey Rep (2013) 0.90
Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD. Clin J Am Soc Nephrol (2013) 0.90
Genetic variation in a member of the laminin gene family affects variation in body composition in Drosophila and humans. BMC Genet (2008) 0.89
A higher-carbohydrate, lower-fat diet reduces fasting glucose concentration and improves β-cell function in individuals with impaired fasting glucose. Metabolism (2011) 0.88
Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. Am J Kidney Dis (2012) 0.87
Reversible subclinical hypothyroidism in the presence of adrenal insufficiency. Endocr Pract (2006) 0.87
Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and β-cell function in overweight adults. J Clin Endocrinol Metab (2013) 0.87
Effects of diet macronutrient composition on body composition and fat distribution during weight maintenance and weight loss. Obesity (Silver Spring) (2013) 0.86
Neighborhood perceptions affect dietary behaviors and diet quality. J Nutr Educ Behav (2010) 0.86
Body fat and racial genetic admixture are associated with aerobic fitness levels in a multiethnic pediatric population. Obesity (Silver Spring) (2011) 0.86
Ancestry-informative markers on chromosomes 2, 8 and 15 are associated with insulin-related traits in a racially diverse sample of children. Hum Genomics (2011) 0.86
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease. Am J Hypertens (2012) 0.86
Adjusting adiposity and body weight measurements for height alters the relationship with blood pressure in children. Am J Hypertens (2010) 0.85
Psychosocial risk factors for eating disorders in Hispanic females of diverse ethnic background and non-Hispanic females. Eat Behav (2005) 0.84
Disruptions in energy balance: does nature overcome nurture? Physiol Behav (2007) 0.83
Circulating ghrelin and GLP-1 are not affected by habitual diet. Regul Pept (2012) 0.82
Healthy behaviors, risk factor control and awareness of chronic kidney disease. Am J Nephrol (2013) 0.82
The association between race and income on risk of mortality in patients with moderate chronic kidney disease. BMC Nephrol (2014) 0.82
Reduced carbohydrate diet to improve metabolic outcomes and decrease adiposity in obese peripubertal African American girls. J Pediatr Gastroenterol Nutr (2012) 0.82
Getting to the height of the matter: the relationship between stature and adiposity in pre-pubertal children. Ethn Dis (2013) 0.81
The role of European genetic admixture in the etiology of the insulin resistance syndrome in children: are the effects mediated by fat accumulation? J Pediatr (2010) 0.81
Associations among calcium intake, resting energy expenditure, and body fat in a multiethnic sample of children. J Pediatr (2010) 0.81
Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD. Clin J Am Soc Nephrol (2013) 0.81
Myths, presumptions, and facts about obesity. N Engl J Med (2013) 0.79
Invasive giant prolactinoma presenting as a nasal polyp. J Pediatr (2012) 0.78
Glycemic control and diabetic dyslipidemia in adolescents with type 2 diabetes. Endocr Pract (2013) 0.77
Vitamin D and calcium-sensing receptor polymorphisms differentially associate with resting energy expenditure in peripubertal children. J Bone Miner Metab (2013) 0.77
Low income, community poverty and risk of end stage renal disease. BMC Nephrol (2014) 0.77
Does fat fuel the fire: independent and interactive effects of genetic, physiological, and environmental factors on variations in fat deposition and distribution across populations. J Pediatr Endocrinol Metab (2010) 0.77
Serum 25-hydroxyvitamin D and Ethnic Differences in Arterial Stiffness and Endothelial Function. J Clin Med Res (2012) 0.76
Home-schooled children are thinner, leaner, and report better diets relative to traditionally schooled children. Obesity (Silver Spring) (2013) 0.76
Fibroblast growth factor 23, vitamin D, and health disparities among African Americans with chronic kidney disease. Semin Nephrol (2013) 0.76
Higher postprandial serum ghrelin among African-American girls before puberty. J Pediatr Endocrinol Metab (2012) 0.75
α-Klotho and kidney function decline: an important step forward in understanding the link between mineral metabolism and kidney disease progression. Am J Kidney Dis (2013) 0.75
Associations of blood pressure, sunlight, and vitamin D in community-dwelling adults. J Hypertens (2016) 0.75
Effects of habitual diet on ethnic differences in serum total ghrelin. Endocrine (2012) 0.75
Reply to MF McCarty. Am J Clin Nutr (2014) 0.75
Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl. J Clin Endocrinol Metab (2011) 0.75
Macronutrient intake influences the effect of 25-hydroxy-vitamin d status on metabolic syndrome outcomes in african american girls. Cholesterol (2012) 0.75
Association of urinary uromodulin with kidney function decline and mortality: the health ABC study . Clin Nephrol (2017) 0.75
CDE and non-CDE dietitians' knowledge of exercise and content of exercise programs for older adults with type 2 diabetes. J Nutr Educ Behav (2006) 0.75
Metformin treatment improves weight and dyslipidemia in children with metabolic syndrome. J Pediatr Endocrinol Metab (2015) 0.75
DIABETES AND PREDIABETES ARE SIGNIFICANTLY HIGHER IN MORBIDLY OBESE CHILDREN COMPARED WITH OBESE CHILDREN. Endocr Pract (2015) 0.75
18-year-old college woman with weight loss. Pediatr Nurs (2005) 0.75
Parental perspectives of diabetes management in Alabama public schools. South Med J (2013) 0.75